Skip to content
Kalpvruksh Markets
Offline Log in

NEPHROPLUSNSEOffline

NEPHROCARE HEALTH SE · INE428V01029 · Small Cap · #744
603.10−19.25 (−3.09%)last close · 05 Nov 2026
Prev close
622.35
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹5,750 cr
52-week range · to 05 Nov 2026449.15765.35

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

NEPHROPLUS is 21% below its 52-week high, below its 200-day average — a Small Cap company, #744 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • below its 20 / 50 / 200-day averages · 21% below its 52-week high
  • −13.2% vs Nifty 500
  • traded value 1.0× usual · delivery 51% vs 54% usual
  • FPI +3.0 pp · DII −0.9 pp · MF schemes in Sept 2026: 14 bought, 2 cut · no promoter pledge · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹5,750 cr
Rank
#744
Cap band
Small Cap
Nearest cut-off — Mid / Small
−83.18% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.1×
median 82,206
Delivered
91,934
Of volume
46%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week−4.0%−9.4 pts—
1 month−5.0%−9.1 pts—
3 months−15.0%−13.2 pts—
6 months+12.8%+12.3 pts—
1 year———

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
−2.2%
below
vs 50-day average
−9.8%
below
vs 200-day average
−2.8%
below
ATR (14)
3.5%
typical daily range
Volatility
27%
1 month, annualised
Beta
0.70
vs Nifty 500, 1 year
Traded value
1.0×
vs usual
Delivery
51%
usual 54%
From the 52-week high
−21.2%
place in range 49% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters63.9%63.9%63.9%58.3% −5.5
FPI3.6%9.9% +6.38.8% −1.211.7% +3.0
Mutual funds3.4%3.2% −0.33.2%3.9% +0.7
Other DII4.3%5.5% +1.25.9% +0.44.2% −1.7
Individuals11.3%5.1% −6.35.7% +0.68.7% +3.0
Others13.5%12.5% −1.012.6% +0.113.1% +0.5

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Dec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
56,735
Individuals
52,773

Indian passive funds’ stake

2026-06-30

Of free float
0.00%
Of all shares
0.00%
Schemes
3
Days to unwind
<0.1
at 100% of volume

962 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
14
3 index · 11 active
Bought more
2
Sold some
1
FundSharesChangeDid
ICICI Pru Retirement Fund-Hybrid Aggressive Plan(G)Active−27,736−12.8%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 262110411+15.8%₹226 cr
Aug 26120220−2.0%₹202 cr
Jul 26120421−5.0%₹205 cr
Jun 26134120+21.9%₹215 cr
May 2691021−15.5%₹156 cr
Apr 2690020−0.7%₹163 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Nephrocare Health Services Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    04 Nov 2026
  • Credit rating
    Nephrocare Health Services Limited has informed the Exchange about Credit Rating- Revision
    21 Sept 2026
  • Board outcome
    Nephrocare Health Services Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    12 Aug 2026
  • Insider trade
    Nephrocare Health Services Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
    06 Aug 2026
  • Takeover (SAST)
    Investcorp Growth Opportunity Fund has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
    16 Jun 2026
  • Takeover (SAST)
    Investcorp Private Equity Fund II has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
    16 Jun 2026
  • Bulk deal: SELL
    8,42,109 at ₹705.03 — EDORAS INVESTMENT HOLDINGS PTE LTD
    24 Sept 2026
  • Bulk deal: SELL
    8,42,109 at ₹710.18 — EDORAS INVESTMENT HOLDINGS PTE LTD
    24 Sept 2026
  • Bulk deal: SELL
    8,15,776 at ₹710.45 — MANSI SHARE AND STOCK BROKING PRIVATE LIMITED
    24 Sept 2026
  • Bulk deal: BUY
    8,23,311 at ₹705.24 — MANSI SHARE AND STOCK BROKING PRIVATE LIMITED
    24 Sept 2026

Latest shown; 13 in six months on all disclosures.

NEPHROPLUS: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.